{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:57:51Z","timestamp":1760853471153,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T00:00:00Z","timestamp":1278633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00210-010-0534-5","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T02:16:21Z","timestamp":1278555381000},"page":"177-191","source":"Crossref","is-referenced-by-count":10,"title":["Establishment of recombinant cannabinoid receptor assays and characterization of several natural and synthetic ligands"],"prefix":"10.1007","volume":"382","author":[{"given":"Sarah","family":"Geiger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Nickl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich H.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,9]]},"reference":[{"key":"534_CR1","unstructured":"Breivogel C (2006) Cannabinoid receptor binding to membrane homogenates and cannabinoid-stimulated [35S]GTP\u03b3S binding to membrane homogenates or intact cultured cells, in Methods in Molecular Medicine: Marijuana and Cannabinoid Research: Methods and Protocols; ed. Onaivi ES, Humana, Totowa, NJ"},{"key":"534_CR2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1471-4159.2000.0751335.x","volume":"75","author":"SA Burchett","year":"2000","unstructured":"Burchett SA (2000) Regulators of G protein signaling: a bestiary of modular protein binding domains. J Neurochem 75:1335\u20131351","journal-title":"J Neurochem"},{"key":"534_CR3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2007.02.004","volume":"28","author":"D Centonze","year":"2007","unstructured":"Centonze D, Finazzi-Agro A, Bernardi G, Maccarrone M (2007) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci 28:180\u2013187","journal-title":"Trends Pharmacol Sci"},{"key":"534_CR4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1517\/13543784.16.7.951","volume":"16","author":"Y Cheng","year":"2007","unstructured":"Cheng Y, Hitchcock SA (2007) Targeting cannabinoid agonists for inflammatory and neuropathic pain. Expert Opin Investig Drugs 16:951\u2013965","journal-title":"Expert Opin Investig Drugs"},{"key":"534_CR5","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099\u20133108","journal-title":"Biochem Pharmacol"},{"key":"534_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1098-2396(20001215)38:4<477::AID-SYN13>3.0.CO;2-Y","volume":"38","author":"M Cosenza","year":"2000","unstructured":"Cosenza M, Gifford AN, Gatley SJ, Pyatt B, Liu Q, Makriyannis A, Volkow ND (2000) Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist\/inverse agonist AM281. Synapse 38:477\u2013482","journal-title":"Synapse"},{"key":"534_CR7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.bjp.0705666","volume":"141","author":"L Petrocellis De","year":"2004","unstructured":"De Petrocellis L, Cascio MG, Di Marzo V (2004) The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141:765\u2013774","journal-title":"Br J Pharmacol"},{"key":"534_CR8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","volume":"3","author":"V Marzo Di","year":"2004","unstructured":"Di Marzo V, Bifulco M, De Petrocellis L (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3:771\u2013784","journal-title":"Nat Rev Drug Discov"},{"key":"534_CR9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","volume":"48","author":"CC Felder","year":"1995","unstructured":"Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443\u2013450","journal-title":"Mol Pharmacol"},{"key":"534_CR10","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"105","author":"J Gertsch","year":"2008","unstructured":"Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A (2008) \u03b2-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 105:9099\u20139104","journal-title":"Proc Natl Acad Sci USA"},{"key":"534_CR11","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1074\/jbc.272.5.2587","volume":"72","author":"U Gether","year":"1997","unstructured":"Gether U, Ballesteros JA, Seifert R, Sanders-Bush E, Weinstein H, Kobilka BK (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 72:2587\u20132590","journal-title":"J Biol Chem"},{"key":"534_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0922-4106(89)90031-X","volume":"172","author":"P Gierschik","year":"1989","unstructured":"Gierschik P, Sidiropoulos D, Steisslinger M, Jakobs KH (1989) Na+ regulation of formyl peptide receptor-mediated signal transduction in HL 60 cells. Evidence that the cation prevents activation of the G-protein by unoccupied receptors. Eur J Pharmacol 172:481\u2013492","journal-title":"Eur J Pharmacol"},{"key":"534_CR13","first-page":"725","volume":"197","author":"P Gierschik","year":"1991","unstructured":"Gierschik P, Moghtader R, Straub C, Dieterich K, Jakobs KH (1991) Signal amplification in HL-60 granulocytes. Evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes. Eur J Pharmacol 197:725\u2013732","journal-title":"Eur J Pharmacol"},{"key":"534_CR14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3565(24)37418-X","volume":"285","author":"G Griffin","year":"1998","unstructured":"Griffin G, Atkinson PJ, Showalter VM, Martin BR, Abood ME (1998) Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5\u2032-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. J Pharmacol Exp Ther 285:553\u2013560","journal-title":"J Pharmacol Exp Ther"},{"key":"534_CR15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ciuz.200700427","volume":"41","author":"J Heilmann","year":"2007","unstructured":"Heilmann J (2007) Wirkstoffe auf der Basis von biologisch aktiven Naturstoffen. Chemie in unserer Zeit 41:376\u2013389","journal-title":"Chemie in unserer Zeit"},{"key":"534_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161\u2013202","journal-title":"Pharmacol Rev"},{"key":"534_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00210-008-0313-8","volume":"378","author":"P Kleemann","year":"2008","unstructured":"Kleemann P, Papa D, Vigil-Cruz S, Seifert R (2008) Functional reconstitution of the human chemokine receptor CXCR4 with Gi\/Go-proteins in Sf9 insect cells. Naunyn Schmiedeberg\u2019s Arch Pharmacol 378:261\u2013274","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"534_CR18","first-page":"E4","volume":"1","author":"R Lan","year":"1999","unstructured":"Lan R, Gatley J, Lu Q, Fan P, Fernando SR, Volkow ND, Pertwee R, Makriyannis A (1999a) Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. AAPS Pharm Sci 1:E4","journal-title":"AAPS Pharm Sci"},{"key":"534_CR19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","volume":"42","author":"R Lan","year":"1999","unstructured":"Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, Makriyannis A (1999b) Structure\u2013activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42:769\u2013776","journal-title":"J Med Chem"},{"key":"534_CR20","doi-asserted-by":"crossref","first-page":"36013","DOI":"10.1074\/jbc.M403990200","volume":"279","author":"C Leterrier","year":"2004","unstructured":"Leterrier C, Bonnard D, Carrel D, Rossier J, Lenkei Z (2004) Constitutive endocytic cycle of the CB1 cannabinoid receptor. J Biol Chem 279:36013\u201336021","journal-title":"J Biol Chem"},{"key":"534_CR21","first-page":"265","volume-title":"Cannabinoids and pain, in Handb Exp Pharmacol","author":"IJ Lever","year":"2007","unstructured":"Lever IJ, Rice AS (2007) Cannabinoids and pain, in Handb Exp Pharmacol. Springer, Berlin, pp 265\u2013306"},{"key":"534_CR22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","volume":"302","author":"G Marsicano","year":"2003","unstructured":"Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Guti\u00e9rrez SO, van der Stelt M, L\u00f3pez-Rodriguez ML, Casanova E, Sch\u00fctz G, Zieglg\u00e4nsberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid receptors and on-demand defence against exocitotoxicity. Science 302:84\u201388","journal-title":"Science"},{"key":"534_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0378-1119(03)00638-3","volume":"312","author":"JM McPartland","year":"2003","unstructured":"McPartland JM, Glass M (2003) Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates. Gene 312:297\u2013303","journal-title":"Gene"},{"key":"534_CR24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cne.1078","volume":"436","author":"J McPartland","year":"2001","unstructured":"McPartland J, Di Marzo V, De Petrocellis L, Mercer A, Glass M (2001) Cannabinoid receptors are absent in insects. J J Comp Neurol 436:423\u2013429","journal-title":"J J Comp Neurol"},{"key":"534_CR25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","volume":"152","author":"JM McPartland","year":"2007","unstructured":"McPartland JM, Glass M, Pertwee RG (2007) Meta-analysis of cannabinoid binding affinity and receptor distribution: interspecies differences. Br J Pharmacol 152:583\u2013592","journal-title":"Br J Pharmacol"},{"key":"534_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83\u201390","journal-title":"Biochem Pharmacol"},{"key":"534_CR27","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1476-5381.2009.00124.x","volume":"156","author":"HA Navarro","year":"2009","unstructured":"Navarro HA, Howard JL, Pollard GT, Carroll FI (2009) Positive allosteric modulation of the human cannabinoid (CB1) receptor by RTI-371, a selective inhibitor of the dopamine transporter. Br J Pharmacol 156:1178\u20131184","journal-title":"Br J Pharmacol"},{"key":"534_CR28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2008.09.078","volume":"447","author":"K Nickl","year":"2008","unstructured":"Nickl K, Gardner EE, Geiger S, Heilmann J, Seifert R (2008) Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G\u03b1i2\u03b21\u03b32. Neurosci Lett 447:68\u201372","journal-title":"Neurosci Lett"},{"key":"534_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0079-6107(03)00052-X","volume":"83","author":"S Offermanns","year":"2003","unstructured":"Offermanns S (2003) G-proteins as transducers in transmembrane signalling. Prog Biophys Mol Biol 83:101\u2013130","journal-title":"Prog Biophys Mol Biol"},{"key":"534_CR30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","volume":"413","author":"D Panikashvili","year":"2001","unstructured":"Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413:527\u2013531","journal-title":"Nature"},{"key":"534_CR31","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.91.7.2699","volume":"91","author":"G Pei","year":"1994","unstructured":"Pei G, Samama P, Lohse M, Wang M, Codina J, Lefkowitz RJ (1994) A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc Natl Acad Sci USA 91:2699\u20132702","journal-title":"Proc Natl Acad Sci USA"},{"key":"534_CR32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-2006-957605","volume":"63","author":"NB Perry","year":"1997","unstructured":"Perry NB, van Klink JW, Burgess EJ, Parmenter GA (1997) Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers. Planta Med 63:58\u201362","journal-title":"Planta Med"},{"key":"534_CR33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","volume":"6","author":"RG Pertwee","year":"1999","unstructured":"Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635\u2013664","journal-title":"Curr Med Chem"},{"key":"534_CR34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","volume":"13","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008a) Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 13:147\u2013159","journal-title":"Addict Biol"},{"key":"534_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008b) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin. Br J Pharmacol 153:199\u2013215","journal-title":"Br J Pharmacol"},{"key":"534_CR36","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.M601074200","volume":"281","author":"S Raduner","year":"2006","unstructured":"Raduner S, Majewska A, Chen JZ, Xie XQ, Hamon J, Faller B, Altmann KH, Gertsch JH (2006) Alkylamides from Echinacea are a new class cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J Biol Chem 281:14192\u201314206","journal-title":"J Biol Chem"},{"key":"534_CR37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.biochem.69.1.795","volume":"69","author":"EM Ross","year":"2000","unstructured":"Ross EM, Wilkie TM (2000) GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 69:795\u2013827","journal-title":"Annu Rev Biochem"},{"key":"534_CR38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","volume":"126","author":"RA Ross","year":"1999","unstructured":"Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG (1999) Agonist-inverse agonist characterization at CB1 and CB2 receptors of L759633, L759656, and AM630. Br J Pharmacol 126:665\u2013672","journal-title":"Br J Pharmacol"},{"key":"534_CR39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bcp.2009.05.015","volume":"78","author":"EH Schneider","year":"2009","unstructured":"Schneider EH, Seifert R (2009) Histamine H4 receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H4 receptor ligands. Biochem Pharmacol 78:607\u2013616","journal-title":"Biochem Pharmacol"},{"key":"534_CR40","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/bi802050d","volume":"48","author":"EH Schneider","year":"2009","unstructured":"Schneider EH, Schnell D, Papa D, Seifert R (2009) High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor. Biochemistry 48:1424\u20131438","journal-title":"Biochemistry"},{"key":"534_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/mol.108.052944","volume":"75","author":"R Seifert","year":"2009","unstructured":"Seifert R, Dove S (2009) Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities. Mol Pharmacol 75:13\u201318","journal-title":"Mol Pharmacol"},{"key":"534_CR42","first-page":"357","volume":"7","author":"R Seifert","year":"2001","unstructured":"Seifert R, Wenzel-Seifert K (2001) Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state. Recept Channels 7:357\u2013369","journal-title":"Recept Channels"},{"key":"534_CR43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00210-002-0588-0","volume":"366","author":"R Seifert","year":"2002","unstructured":"Seifert R, Wenzel-Seifert K (2002) Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedeberg\u2019s Arch Pharmacol 366:381\u2013416","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"534_CR44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1432-1327.1998.2550369.x","volume":"255","author":"R Seifert","year":"1998","unstructured":"Seifert R, Lee TW, Lam VT, Kobilka BK (1998) Reconstitution of beta2-adrenoceptor-GTP-binding-protein interaction in Sf9 cells\u2014high coupling efficiency in a beta2-adrenoceptor-G(s alpha) fusion protein. Eur J Biochem 255:369\u2013382","journal-title":"Eur J Biochem"},{"key":"534_CR45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/mol.56.2.348","volume":"56","author":"R Seifert","year":"1999","unstructured":"Seifert R, Gether U, Wenzel-Seifert K, Kobilka BK (1999a) Effects of guanine, inosine, and xanthine nucleotides on \u03b22-adrenergic receptor\/Gs interactions: evidence for multiple conformations. Mol Pharmacol 56:348\u2013358","journal-title":"Mol Pharmacol"},{"key":"534_CR46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0165-6147(99)01368-1","volume":"20","author":"R Seifert","year":"1999","unstructured":"Seifert R, Wenzel-Seifert K, Kobilka B (1999b) GPCR\u2013Ga fusion proteins:molecular analysis of receptor\u2013G-protein coupling. Trends Pharmacol Sci 20:383\u2013389","journal-title":"Trends Pharmacol Sci"},{"key":"534_CR47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0022-3565(24)29653-1","volume":"297","author":"R Seifert","year":"2001","unstructured":"Seifert R, Wenzel-Seifert K, Gether U, Kobilka BK (2001) Functional differences between full and parial agonists: evidence for ligand-specific receptor conformations. J Pharmacol Exp Ther 297:1218\u20131226","journal-title":"J Pharmacol Exp Ther"},{"key":"534_CR48","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1021\/jm070566z","volume":"51","author":"R Silvestri","year":"2008","unstructured":"Silvestri R, Cascio MG, La Regina G, Piscitelli F, Lavecchia A, Brizzi A, Pasquini S, Botta M, Novellino E, Di Marzo V, Corelli F (2008) Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. J Med Chem 51:1560\u20131576","journal-title":"J Med Chem"},{"key":"534_CR49","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1073\/pnas.93.9.3984","volume":"93","author":"SD Skaper","year":"1999","unstructured":"Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A (1999) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci 93:3984\u20133989","journal-title":"Proc Natl Acad Sci"},{"key":"534_CR50","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0026-895X(24)12547-3","volume":"56","author":"ZH Song","year":"1999","unstructured":"Song ZH, Slowey CA, Hurst DP, Reggio PH (1999) The difference between the CB1 and CB2 cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN 55, 212\u20132 for CB2. Mol Pharmacol 56:834\u2013840","journal-title":"Mol Pharmacol"},{"key":"534_CR51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)37365-3","volume":"285","author":"BF Thomas","year":"1998","unstructured":"Thomas BF, Gilliam AF, Burch DF, Roche MJ, Seltzman HH (1998) Comparative receptor binding analyses of cannabinoid agonists and antagonists. J Pharmacol Exp Ther 285:285\u2013292","journal-title":"J Pharmacol Exp Ther"},{"key":"534_CR52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0005-2787(79)90122-9","volume":"562","author":"TF Walseth","year":"1979","unstructured":"Walseth TF, Johnson RA (1979) The enzymatic preparation of [\u03b1-32P]nucleoside triphosphates, cyclic [32P]AMP, and cyclic [32P]GMP. Biochim Biophys Acta 562:11\u201331","journal-title":"Biochim Biophys Acta"},{"key":"534_CR53","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/mol.58.5.954","volume":"58","author":"K Wenzel-Seifert","year":"2000","unstructured":"Wenzel-Seifert K, Seifert R (2000) Molecular analysis of \u03b22-adrenoreceptor coupling to Gs-, Gi, and Gq-proteins. Mol Pharmacol 58:954\u2013966","journal-title":"Mol Pharmacol"},{"key":"534_CR54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0006-291X(03)00023-8","volume":"301","author":"K Wenzel-Seifert","year":"2003","unstructured":"Wenzel-Seifert K, Seifert R (2003) Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor. Biochem Biophys Res Commun 301:693\u2013698","journal-title":"Biochem Biophys Res Commun"},{"key":"534_CR55","doi-asserted-by":"crossref","first-page":"24181","DOI":"10.1074\/jbc.273.37.24181","volume":"273","author":"K Wenzel-Seifert","year":"1998","unstructured":"Wenzel-Seifert K, Hurt CM, Seifert R (1998) High constitutive activity of the human formyl peptide receptor. J Biol Chem 273:24181\u201324189","journal-title":"J Biol Chem"},{"key":"534_CR56","doi-asserted-by":"crossref","first-page":"33259","DOI":"10.1074\/jbc.274.47.33259","volume":"274","author":"K Wenzel-Seifert","year":"1999","unstructured":"Wenzel-Seifert K, Arthur JM, Liu HY, Seifert R (1999) Quantitative analysis of formyl peptide receptor coupling to Gi\u03b11, Gi\u03b12, and Gi\u03b13. J Biol Chem 274:33259\u201333266","journal-title":"J Biol Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-010-0534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-010-0534-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-010-0534-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T19:21:49Z","timestamp":1740252109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-010-0534-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,9]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s00210-010-0534-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2010,7,9]]}}}